nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.105	0.128	CbGbCtD
Finasteride—CYP3A7—Temsirolimus—kidney cancer	0.105	0.128	CbGbCtD
Finasteride—CYP3A5—Temsirolimus—kidney cancer	0.0784	0.0963	CbGbCtD
Finasteride—CYP3A4—Everolimus—kidney cancer	0.0453	0.0556	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0359	0.0441	CbGbCtD
Finasteride—CYP3A7—Paclitaxel—kidney cancer	0.0359	0.0441	CbGbCtD
Finasteride—CYP3A7—Sorafenib—kidney cancer	0.0319	0.0391	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0319	0.0391	CbGbCtD
Finasteride—CYP3A7—Vincristine—kidney cancer	0.0309	0.038	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0309	0.038	CbGbCtD
Finasteride—CYP3A4—Temsirolimus—kidney cancer	0.0306	0.0376	CbGbCtD
Finasteride—CYP3A5—Erlotinib—kidney cancer	0.0294	0.0361	CbGbCtD
Finasteride—CYP3A5—Paclitaxel—kidney cancer	0.0269	0.0331	CbGbCtD
Finasteride—CYP3A7—Sunitinib—kidney cancer	0.0258	0.0317	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0258	0.0317	CbGbCtD
Finasteride—CYP3A5—Sorafenib—kidney cancer	0.0239	0.0294	CbGbCtD
Finasteride—CYP3A5—Vincristine—kidney cancer	0.0232	0.0285	CbGbCtD
Finasteride—CYP3A5—Sunitinib—kidney cancer	0.0194	0.0238	CbGbCtD
Finasteride—CYP3A4—Pazopanib—kidney cancer	0.0161	0.0197	CbGbCtD
Finasteride—Infertility male—Everolimus—kidney cancer	0.0135	0.0998	CcSEcCtD
Finasteride—CYP3A4—Erlotinib—kidney cancer	0.0115	0.0141	CbGbCtD
Finasteride—CYP3A4—Paclitaxel—kidney cancer	0.0105	0.0129	CbGbCtD
Finasteride—CYP3A4—Sorafenib—kidney cancer	0.00932	0.0114	CbGbCtD
Finasteride—CYP3A4—Vinblastine—kidney cancer	0.0092	0.0113	CbGbCtD
Finasteride—CYP3A4—Vincristine—kidney cancer	0.00904	0.0111	CbGbCtD
Finasteride—CYP3A4—Sunitinib—kidney cancer	0.00755	0.00928	CbGbCtD
Finasteride—CYP3A4—Doxorubicin—kidney cancer	0.00565	0.00695	CbGbCtD
Finasteride—Breast cancer—Everolimus—kidney cancer	0.00427	0.0315	CcSEcCtD
Finasteride—Breast cancer—Gemcitabine—kidney cancer	0.00286	0.0211	CcSEcCtD
Finasteride—Neoplasm malignant—Pazopanib—kidney cancer	0.00231	0.0171	CcSEcCtD
Finasteride—Swelling—Temsirolimus—kidney cancer	0.00172	0.0127	CcSEcCtD
Finasteride—Tenderness—Erlotinib—kidney cancer	0.00172	0.0127	CcSEcCtD
Finasteride—Neoplasm malignant—Sorafenib—kidney cancer	0.00158	0.0117	CcSEcCtD
Finasteride—Neoplasm malignant—Sunitinib—kidney cancer	0.00152	0.0113	CcSEcCtD
Finasteride—Neoplasm—Vinblastine—kidney cancer	0.00141	0.0104	CcSEcCtD
Finasteride—Neoplasm—Everolimus—kidney cancer	0.00141	0.0104	CcSEcCtD
Finasteride—Influenza—Temsirolimus—kidney cancer	0.00131	0.0097	CcSEcCtD
Finasteride—Breast disorder—Pazopanib—kidney cancer	0.0013	0.00956	CcSEcCtD
Finasteride—Bronchitis—Temsirolimus—kidney cancer	0.00126	0.00933	CcSEcCtD
Finasteride—Neoplasm malignant—Gemcitabine—kidney cancer	0.00122	0.00903	CcSEcCtD
Finasteride—Neoplasm—Sorafenib—kidney cancer	0.00122	0.00903	CcSEcCtD
Finasteride—Gynaecomastia—Sorafenib—kidney cancer	0.00121	0.00893	CcSEcCtD
Finasteride—Tenderness—Gemcitabine—kidney cancer	0.0012	0.00884	CcSEcCtD
Finasteride—Neoplasm—Sunitinib—kidney cancer	0.00118	0.00869	CcSEcCtD
Finasteride—Sinusitis—Temsirolimus—kidney cancer	0.0011	0.00812	CcSEcCtD
Finasteride—Prostatic disorder—Doxorubicin—kidney cancer	0.00109	0.00803	CcSEcCtD
Finasteride—Rhinitis—Temsirolimus—kidney cancer	0.00106	0.00778	CcSEcCtD
Finasteride—Pharyngitis—Temsirolimus—kidney cancer	0.00104	0.00771	CcSEcCtD
Finasteride—Oedema peripheral—Temsirolimus—kidney cancer	0.00104	0.00765	CcSEcCtD
Finasteride—Breast disorder—Everolimus—kidney cancer	0.00102	0.00754	CcSEcCtD
Finasteride—Tenderness—Paclitaxel—kidney cancer	0.001	0.0074	CcSEcCtD
Finasteride—Influenza—Everolimus—kidney cancer	0.000978	0.00722	CcSEcCtD
Finasteride—Oedema peripheral—Pazopanib—kidney cancer	0.000977	0.00721	CcSEcCtD
Finasteride—Immune system disorder—Temsirolimus—kidney cancer	0.000951	0.00701	CcSEcCtD
Finasteride—Bronchitis—Everolimus—kidney cancer	0.000941	0.00694	CcSEcCtD
Finasteride—Mental disorder—Temsirolimus—kidney cancer	0.000922	0.0068	CcSEcCtD
Finasteride—Erectile dysfunction—Everolimus—kidney cancer	0.000901	0.00665	CcSEcCtD
Finasteride—Breast disorder—Sorafenib—kidney cancer	0.000888	0.00655	CcSEcCtD
Finasteride—Mental disorder—Pazopanib—kidney cancer	0.000869	0.00641	CcSEcCtD
Finasteride—Angioedema—Temsirolimus—kidney cancer	0.000837	0.00618	CcSEcCtD
Finasteride—Sinusitis—Everolimus—kidney cancer	0.000818	0.00604	CcSEcCtD
Finasteride—Neoplasm—Paclitaxel—kidney cancer	0.000791	0.00584	CcSEcCtD
Finasteride—Bronchitis—Sunitinib—kidney cancer	0.000786	0.0058	CcSEcCtD
Finasteride—Rhinitis—Everolimus—kidney cancer	0.000785	0.00579	CcSEcCtD
Finasteride—Erectile dysfunction—Sorafenib—kidney cancer	0.000782	0.00577	CcSEcCtD
Finasteride—Pharyngitis—Vinblastine—kidney cancer	0.00078	0.00575	CcSEcCtD
Finasteride—Pharyngitis—Everolimus—kidney cancer	0.000777	0.00573	CcSEcCtD
Finasteride—SRD5A1—renal system—kidney cancer	0.000776	0.224	CbGeAlD
Finasteride—Oedema peripheral—Everolimus—kidney cancer	0.000771	0.00569	CcSEcCtD
Finasteride—Infection—Temsirolimus—kidney cancer	0.000743	0.00548	CcSEcCtD
Finasteride—Swelling—Paclitaxel—kidney cancer	0.00072	0.00531	CcSEcCtD
Finasteride—Immune system disorder—Everolimus—kidney cancer	0.000707	0.00522	CcSEcCtD
Finasteride—Infection—Pazopanib—kidney cancer	0.0007	0.00516	CcSEcCtD
Finasteride—SRD5A1—gonad—kidney cancer	0.000695	0.201	CbGeAlD
Finasteride—Injury—Paclitaxel—kidney cancer	0.000691	0.0051	CcSEcCtD
Finasteride—Mental disorder—Everolimus—kidney cancer	0.000686	0.00506	CcSEcCtD
Finasteride—Dyspnoea—Temsirolimus—kidney cancer	0.000667	0.00492	CcSEcCtD
Finasteride—Somnolence—Temsirolimus—kidney cancer	0.000665	0.0049	CcSEcCtD
Finasteride—Mental disorder—Erlotinib—kidney cancer	0.000662	0.00488	CcSEcCtD
Finasteride—Influenza—Gemcitabine—kidney cancer	0.000655	0.00484	CcSEcCtD
Finasteride—Neoplasm—Capecitabine—kidney cancer	0.000649	0.00479	CcSEcCtD
Finasteride—Oedema peripheral—Sunitinib—kidney cancer	0.000644	0.00475	CcSEcCtD
Finasteride—Pain—Temsirolimus—kidney cancer	0.000639	0.00472	CcSEcCtD
Finasteride—Erectile dysfunction—Vincristine—kidney cancer	0.000636	0.0047	CcSEcCtD
Finasteride—Dyspnoea—Pazopanib—kidney cancer	0.000628	0.00463	CcSEcCtD
Finasteride—Somnolence—Pazopanib—kidney cancer	0.000626	0.00462	CcSEcCtD
Finasteride—Angioedema—Everolimus—kidney cancer	0.000623	0.00459	CcSEcCtD
Finasteride—Pharyngitis—Dactinomycin—kidney cancer	0.000614	0.00453	CcSEcCtD
Finasteride—Immune system disorder—Sorafenib—kidney cancer	0.000614	0.00453	CcSEcCtD
Finasteride—Pain—Pazopanib—kidney cancer	0.000602	0.00444	CcSEcCtD
Finasteride—Mental disorder—Sorafenib—kidney cancer	0.000595	0.00439	CcSEcCtD
Finasteride—Swelling—Capecitabine—kidney cancer	0.000591	0.00436	CcSEcCtD
Finasteride—Immune system disorder—Sunitinib—kidney cancer	0.000591	0.00436	CcSEcCtD
Finasteride—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00058	0.00428	CcSEcCtD
Finasteride—Breast disorder—Paclitaxel—kidney cancer	0.000574	0.00423	CcSEcCtD
Finasteride—Mental disorder—Sunitinib—kidney cancer	0.000573	0.00423	CcSEcCtD
Finasteride—Libido decreased—Capecitabine—kidney cancer	0.000562	0.00415	CcSEcCtD
Finasteride—Infection—Everolimus—kidney cancer	0.000553	0.00408	CcSEcCtD
Finasteride—Hypersensitivity—Temsirolimus—kidney cancer	0.000551	0.00406	CcSEcCtD
Finasteride—Influenza—Paclitaxel—kidney cancer	0.000549	0.00405	CcSEcCtD
Finasteride—Neoplasm malignant—Doxorubicin—kidney cancer	0.000542	0.004	CcSEcCtD
Finasteride—Angioedema—Sorafenib—kidney cancer	0.000541	0.00399	CcSEcCtD
Finasteride—Asthenia—Temsirolimus—kidney cancer	0.000536	0.00396	CcSEcCtD
Finasteride—Infection—Erlotinib—kidney cancer	0.000533	0.00393	CcSEcCtD
Finasteride—Pruritus—Temsirolimus—kidney cancer	0.000529	0.0039	CcSEcCtD
Finasteride—Bronchitis—Paclitaxel—kidney cancer	0.000528	0.00389	CcSEcCtD
Finasteride—Rhinitis—Gemcitabine—kidney cancer	0.000526	0.00388	CcSEcCtD
Finasteride—Pharyngitis—Gemcitabine—kidney cancer	0.000521	0.00384	CcSEcCtD
Finasteride—Angioedema—Sunitinib—kidney cancer	0.00052	0.00384	CcSEcCtD
Finasteride—Hypotension—Everolimus—kidney cancer	0.00052	0.00383	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.000517	0.00381	CcSEcCtD
Finasteride—Oedema peripheral—Gemcitabine—kidney cancer	0.000517	0.00381	CcSEcCtD
Finasteride—Asthenia—Pazopanib—kidney cancer	0.000505	0.00373	CcSEcCtD
Finasteride—Pruritus—Pazopanib—kidney cancer	0.000498	0.00368	CcSEcCtD
Finasteride—Dyspnoea—Everolimus—kidney cancer	0.000496	0.00366	CcSEcCtD
Finasteride—Somnolence—Everolimus—kidney cancer	0.000494	0.00365	CcSEcCtD
Finasteride—Dizziness—Temsirolimus—kidney cancer	0.000494	0.00365	CcSEcCtD
Finasteride—Mental disorder—Vincristine—kidney cancer	0.000485	0.00358	CcSEcCtD
Finasteride—Infection—Sorafenib—kidney cancer	0.00048	0.00354	CcSEcCtD
Finasteride—Dyspnoea—Erlotinib—kidney cancer	0.000478	0.00353	CcSEcCtD
Finasteride—Pain—Vinblastine—kidney cancer	0.000477	0.00352	CcSEcCtD
Finasteride—Orthostatic hypotension—Capecitabine—kidney cancer	0.000476	0.00351	CcSEcCtD
Finasteride—Pain—Everolimus—kidney cancer	0.000476	0.00351	CcSEcCtD
Finasteride—Immune system disorder—Gemcitabine—kidney cancer	0.000474	0.0035	CcSEcCtD
Finasteride—Rash—Temsirolimus—kidney cancer	0.000471	0.00348	CcSEcCtD
Finasteride—Dermatitis—Temsirolimus—kidney cancer	0.000471	0.00348	CcSEcCtD
Finasteride—Breast disorder—Capecitabine—kidney cancer	0.000471	0.00347	CcSEcCtD
Finasteride—Headache—Temsirolimus—kidney cancer	0.000468	0.00346	CcSEcCtD
Finasteride—Dizziness—Pazopanib—kidney cancer	0.000466	0.00344	CcSEcCtD
Finasteride—Infection—Sunitinib—kidney cancer	0.000462	0.00341	CcSEcCtD
Finasteride—Sinusitis—Paclitaxel—kidney cancer	0.000459	0.00339	CcSEcCtD
Finasteride—Pain—Erlotinib—kidney cancer	0.000459	0.00339	CcSEcCtD
Finasteride—CYP3A4—urine—kidney cancer	0.000454	0.131	CbGeAlD
Finasteride—Influenza—Capecitabine—kidney cancer	0.00045	0.00332	CcSEcCtD
Finasteride—Rash—Pazopanib—kidney cancer	0.000444	0.00328	CcSEcCtD
Finasteride—Dermatitis—Pazopanib—kidney cancer	0.000444	0.00327	CcSEcCtD
Finasteride—Headache—Pazopanib—kidney cancer	0.000441	0.00326	CcSEcCtD
Finasteride—Rhinitis—Paclitaxel—kidney cancer	0.00044	0.00325	CcSEcCtD
Finasteride—Infection—Dactinomycin—kidney cancer	0.000437	0.00322	CcSEcCtD
Finasteride—Pharyngitis—Paclitaxel—kidney cancer	0.000436	0.00322	CcSEcCtD
Finasteride—Bronchitis—Capecitabine—kidney cancer	0.000433	0.0032	CcSEcCtD
Finasteride—Oedema peripheral—Paclitaxel—kidney cancer	0.000433	0.00319	CcSEcCtD
Finasteride—Dyspnoea—Sorafenib—kidney cancer	0.00043	0.00318	CcSEcCtD
Finasteride—Neoplasm—Doxorubicin—kidney cancer	0.000418	0.00309	CcSEcCtD
Finasteride—Dyspnoea—Sunitinib—kidney cancer	0.000414	0.00306	CcSEcCtD
Finasteride—Pain—Sorafenib—kidney cancer	0.000413	0.00305	CcSEcCtD
Finasteride—Hypersensitivity—Vinblastine—kidney cancer	0.000411	0.00304	CcSEcCtD
Finasteride—Hypersensitivity—Everolimus—kidney cancer	0.00041	0.00302	CcSEcCtD
Finasteride—Asthenia—Vinblastine—kidney cancer	0.000401	0.00296	CcSEcCtD
Finasteride—Asthenia—Everolimus—kidney cancer	0.000399	0.00294	CcSEcCtD
Finasteride—Pain—Sunitinib—kidney cancer	0.000397	0.00293	CcSEcCtD
Finasteride—Immune system disorder—Paclitaxel—kidney cancer	0.000397	0.00293	CcSEcCtD
Finasteride—Pruritus—Everolimus—kidney cancer	0.000393	0.0029	CcSEcCtD
Finasteride—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000393	0.113	CbGeAlD
Finasteride—Infection—Vincristine—kidney cancer	0.00039	0.00288	CcSEcCtD
Finasteride—Asthenia—Erlotinib—kidney cancer	0.000385	0.00284	CcSEcCtD
Finasteride—Mental disorder—Paclitaxel—kidney cancer	0.000385	0.00284	CcSEcCtD
Finasteride—Urticaria—Sorafenib—kidney cancer	0.000384	0.00283	CcSEcCtD
Finasteride—Pruritus—Erlotinib—kidney cancer	0.00038	0.0028	CcSEcCtD
Finasteride—Pain—Dactinomycin—kidney cancer	0.000376	0.00277	CcSEcCtD
Finasteride—Infection—Gemcitabine—kidney cancer	0.00037	0.00273	CcSEcCtD
Finasteride—Dizziness—Vinblastine—kidney cancer	0.000369	0.00272	CcSEcCtD
Finasteride—Dizziness—Everolimus—kidney cancer	0.000368	0.00271	CcSEcCtD
Finasteride—Hypotension—Vincristine—kidney cancer	0.000367	0.00271	CcSEcCtD
Finasteride—Rhinitis—Capecitabine—kidney cancer	0.000361	0.00267	CcSEcCtD
Finasteride—Pharyngitis—Capecitabine—kidney cancer	0.000358	0.00264	CcSEcCtD
Finasteride—Hypersensitivity—Sorafenib—kidney cancer	0.000356	0.00262	CcSEcCtD
Finasteride—Oedema peripheral—Capecitabine—kidney cancer	0.000355	0.00262	CcSEcCtD
Finasteride—Dizziness—Erlotinib—kidney cancer	0.000355	0.00262	CcSEcCtD
Finasteride—Rash—Everolimus—kidney cancer	0.000351	0.00259	CcSEcCtD
Finasteride—Dermatitis—Everolimus—kidney cancer	0.00035	0.00259	CcSEcCtD
Finasteride—Headache—Vinblastine—kidney cancer	0.00035	0.00258	CcSEcCtD
Finasteride—Angioedema—Paclitaxel—kidney cancer	0.000349	0.00258	CcSEcCtD
Finasteride—Headache—Everolimus—kidney cancer	0.000348	0.00257	CcSEcCtD
Finasteride—Hypotension—Gemcitabine—kidney cancer	0.000348	0.00257	CcSEcCtD
Finasteride—Asthenia—Sorafenib—kidney cancer	0.000346	0.00256	CcSEcCtD
Finasteride—Hypersensitivity—Sunitinib—kidney cancer	0.000342	0.00253	CcSEcCtD
Finasteride—Pruritus—Sorafenib—kidney cancer	0.000342	0.00252	CcSEcCtD
Finasteride—Rash—Erlotinib—kidney cancer	0.000338	0.0025	CcSEcCtD
Finasteride—Dermatitis—Erlotinib—kidney cancer	0.000338	0.00249	CcSEcCtD
Finasteride—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000336	0.0971	CbGeAlD
Finasteride—Headache—Erlotinib—kidney cancer	0.000336	0.00248	CcSEcCtD
Finasteride—Pain—Vincristine—kidney cancer	0.000336	0.00248	CcSEcCtD
Finasteride—Asthenia—Sunitinib—kidney cancer	0.000333	0.00246	CcSEcCtD
Finasteride—Dyspnoea—Gemcitabine—kidney cancer	0.000332	0.00245	CcSEcCtD
Finasteride—Somnolence—Gemcitabine—kidney cancer	0.000331	0.00244	CcSEcCtD
Finasteride—Pruritus—Sunitinib—kidney cancer	0.000329	0.00243	CcSEcCtD
Finasteride—Immune system disorder—Capecitabine—kidney cancer	0.000326	0.0024	CcSEcCtD
Finasteride—Hypersensitivity—Dactinomycin—kidney cancer	0.000324	0.00239	CcSEcCtD
Finasteride—Dizziness—Sorafenib—kidney cancer	0.000319	0.00236	CcSEcCtD
Finasteride—Pain—Gemcitabine—kidney cancer	0.000319	0.00235	CcSEcCtD
Finasteride—Mental disorder—Capecitabine—kidney cancer	0.000316	0.00233	CcSEcCtD
Finasteride—Asthenia—Dactinomycin—kidney cancer	0.000316	0.00233	CcSEcCtD
Finasteride—Infection—Paclitaxel—kidney cancer	0.00031	0.00229	CcSEcCtD
Finasteride—Dizziness—Sunitinib—kidney cancer	0.000307	0.00227	CcSEcCtD
Finasteride—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000307	0.00226	CcSEcCtD
Finasteride—Rash—Sorafenib—kidney cancer	0.000304	0.00225	CcSEcCtD
Finasteride—Dermatitis—Sorafenib—kidney cancer	0.000304	0.00224	CcSEcCtD
Finasteride—Breast disorder—Doxorubicin—kidney cancer	0.000304	0.00224	CcSEcCtD
Finasteride—Headache—Sorafenib—kidney cancer	0.000302	0.00223	CcSEcCtD
Finasteride—Rash—Sunitinib—kidney cancer	0.000293	0.00216	CcSEcCtD
Finasteride—Dermatitis—Sunitinib—kidney cancer	0.000293	0.00216	CcSEcCtD
Finasteride—Hypotension—Paclitaxel—kidney cancer	0.000292	0.00215	CcSEcCtD
Finasteride—Headache—Sunitinib—kidney cancer	0.000291	0.00215	CcSEcCtD
Finasteride—Influenza—Doxorubicin—kidney cancer	0.00029	0.00214	CcSEcCtD
Finasteride—Hypersensitivity—Vincristine—kidney cancer	0.000289	0.00214	CcSEcCtD
Finasteride—Asthenia—Vincristine—kidney cancer	0.000282	0.00208	CcSEcCtD
Finasteride—Bronchitis—Doxorubicin—kidney cancer	0.000279	0.00206	CcSEcCtD
Finasteride—Dyspnoea—Paclitaxel—kidney cancer	0.000278	0.00205	CcSEcCtD
Finasteride—Somnolence—Paclitaxel—kidney cancer	0.000277	0.00205	CcSEcCtD
Finasteride—Rash—Dactinomycin—kidney cancer	0.000277	0.00205	CcSEcCtD
Finasteride—Asthenia—Gemcitabine—kidney cancer	0.000267	0.00197	CcSEcCtD
Finasteride—Pain—Paclitaxel—kidney cancer	0.000267	0.00197	CcSEcCtD
Finasteride—Pruritus—Gemcitabine—kidney cancer	0.000264	0.00195	CcSEcCtD
Finasteride—Dizziness—Vincristine—kidney cancer	0.00026	0.00192	CcSEcCtD
Finasteride—Infection—Capecitabine—kidney cancer	0.000254	0.00188	CcSEcCtD
Finasteride—Urticaria—Paclitaxel—kidney cancer	0.000248	0.00183	CcSEcCtD
Finasteride—Rash—Vincristine—kidney cancer	0.000248	0.00183	CcSEcCtD
Finasteride—Dermatitis—Vincristine—kidney cancer	0.000248	0.00183	CcSEcCtD
Finasteride—Headache—Vincristine—kidney cancer	0.000246	0.00182	CcSEcCtD
Finasteride—Sinusitis—Doxorubicin—kidney cancer	0.000243	0.00179	CcSEcCtD
Finasteride—Hypotension—Capecitabine—kidney cancer	0.000239	0.00177	CcSEcCtD
Finasteride—Rash—Gemcitabine—kidney cancer	0.000235	0.00173	CcSEcCtD
Finasteride—Dermatitis—Gemcitabine—kidney cancer	0.000235	0.00173	CcSEcCtD
Finasteride—Headache—Gemcitabine—kidney cancer	0.000234	0.00172	CcSEcCtD
Finasteride—Rhinitis—Doxorubicin—kidney cancer	0.000233	0.00172	CcSEcCtD
Finasteride—Pharyngitis—Doxorubicin—kidney cancer	0.000231	0.0017	CcSEcCtD
Finasteride—Hypersensitivity—Paclitaxel—kidney cancer	0.00023	0.0017	CcSEcCtD
Finasteride—Oedema peripheral—Doxorubicin—kidney cancer	0.000229	0.00169	CcSEcCtD
Finasteride—Dyspnoea—Capecitabine—kidney cancer	0.000228	0.00168	CcSEcCtD
Finasteride—Asthenia—Paclitaxel—kidney cancer	0.000224	0.00165	CcSEcCtD
Finasteride—Pruritus—Paclitaxel—kidney cancer	0.000221	0.00163	CcSEcCtD
Finasteride—Pain—Capecitabine—kidney cancer	0.000219	0.00162	CcSEcCtD
Finasteride—Immune system disorder—Doxorubicin—kidney cancer	0.00021	0.00155	CcSEcCtD
Finasteride—Dizziness—Paclitaxel—kidney cancer	0.000206	0.00152	CcSEcCtD
Finasteride—SRD5A2—Metabolism—ST3GAL2—kidney cancer	0.000204	0.00432	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ST3GAL2—kidney cancer	0.000204	0.00432	CbGpPWpGaD
Finasteride—Mental disorder—Doxorubicin—kidney cancer	0.000204	0.0015	CcSEcCtD
Finasteride—Urticaria—Capecitabine—kidney cancer	0.000203	0.0015	CcSEcCtD
Finasteride—SRD5A2—Metabolism—ALDH1A1—kidney cancer	0.000199	0.00422	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALDH1A1—kidney cancer	0.000199	0.00422	CbGpPWpGaD
Finasteride—Rash—Paclitaxel—kidney cancer	0.000197	0.00145	CcSEcCtD
Finasteride—Dermatitis—Paclitaxel—kidney cancer	0.000197	0.00145	CcSEcCtD
Finasteride—AKR1D1—Metabolism—GPC3—kidney cancer	0.000197	0.00416	CbGpPWpGaD
Finasteride—Headache—Paclitaxel—kidney cancer	0.000196	0.00144	CcSEcCtD
Finasteride—SRD5A1—Metabolism—SLC5A3—kidney cancer	0.000191	0.00405	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CA2—kidney cancer	0.000191	0.00405	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC5A3—kidney cancer	0.000191	0.00405	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PGK1—kidney cancer	0.000191	0.00405	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PGK1—kidney cancer	0.000191	0.00405	CbGpPWpGaD
Finasteride—Hypersensitivity—Capecitabine—kidney cancer	0.000189	0.00139	CcSEcCtD
Finasteride—SRD5A1—Metabolism—LDHB—kidney cancer	0.000188	0.00397	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—LDHB—kidney cancer	0.000188	0.00397	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALAD—kidney cancer	0.000186	0.00395	CbGpPWpGaD
Finasteride—Asthenia—Capecitabine—kidney cancer	0.000184	0.00136	CcSEcCtD
Finasteride—AKR1D1—Metabolism—ST3GAL2—kidney cancer	0.000182	0.00385	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000181	0.00384	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000181	0.00384	CbGpPWpGaD
Finasteride—Pruritus—Capecitabine—kidney cancer	0.000181	0.00134	CcSEcCtD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000179	0.00379	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALDH1A1—kidney cancer	0.000178	0.00377	CbGpPWpGaD
Finasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000175	0.00371	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PGK1—kidney cancer	0.00017	0.00361	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC5A3—kidney cancer	0.00017	0.00361	CbGpPWpGaD
Finasteride—Dizziness—Capecitabine—kidney cancer	0.000169	0.00125	CcSEcCtD
Finasteride—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000168	0.00357	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—LDHB—kidney cancer	0.000167	0.00354	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000165	0.00349	CbGpPWpGaD
Finasteride—Infection—Doxorubicin—kidney cancer	0.000164	0.00121	CcSEcCtD
Finasteride—CYP3A5—nephron tubule—kidney cancer	0.000163	0.047	CbGeAlD
Finasteride—SRD5A2—Metabolism—CA9—kidney cancer	0.000163	0.00344	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CA9—kidney cancer	0.000163	0.00344	CbGpPWpGaD
Finasteride—Rash—Capecitabine—kidney cancer	0.000161	0.00119	CcSEcCtD
Finasteride—Dermatitis—Capecitabine—kidney cancer	0.000161	0.00119	CcSEcCtD
Finasteride—Headache—Capecitabine—kidney cancer	0.00016	0.00118	CcSEcCtD
Finasteride—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.00016	0.00338	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	0.000159	0.00337	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000159	0.00337	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000159	0.00337	CbGpPWpGaD
Finasteride—Hypotension—Doxorubicin—kidney cancer	0.000154	0.00114	CcSEcCtD
Finasteride—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000153	0.00324	CbGpPWpGaD
Finasteride—CYP3A5—renal system—kidney cancer	0.000148	0.0427	CbGeAlD
Finasteride—Dyspnoea—Doxorubicin—kidney cancer	0.000147	0.00109	CcSEcCtD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000147	0.00311	CbGpPWpGaD
Finasteride—Somnolence—Doxorubicin—kidney cancer	0.000147	0.00108	CcSEcCtD
Finasteride—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000147	0.00311	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CA9—kidney cancer	0.000145	0.00307	CbGpPWpGaD
Finasteride—CYP3A5—kidney—kidney cancer	0.000143	0.0413	CbGeAlD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000142	0.003	CbGpPWpGaD
Finasteride—Pain—Doxorubicin—kidney cancer	0.000141	0.00104	CcSEcCtD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000141	0.00299	CbGpPWpGaD
Finasteride—CYP3A5—cortex of kidney—kidney cancer	0.000139	0.0402	CbGeAlD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000139	0.00295	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CRABP1—kidney cancer	0.000138	0.00293	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CRABP1—kidney cancer	0.000138	0.00293	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000135	0.00286	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000135	0.00286	CbGpPWpGaD
Finasteride—Urticaria—Doxorubicin—kidney cancer	0.000131	0.000968	CcSEcCtD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000131	0.00277	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000129	0.00274	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTT1—kidney cancer	0.000129	0.00274	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ITPR2—kidney cancer	0.000129	0.00272	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ITPR2—kidney cancer	0.000129	0.00272	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CRABP1—kidney cancer	0.000123	0.00261	CbGpPWpGaD
Finasteride—Hypersensitivity—Doxorubicin—kidney cancer	0.000122	0.000897	CcSEcCtD
Finasteride—CYP3A7—Biological oxidations—PTGS1—kidney cancer	0.000121	0.00257	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000118	0.00251	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000118	0.00251	CbGpPWpGaD
Finasteride—Asthenia—Doxorubicin—kidney cancer	0.000118	0.000874	CcSEcCtD
Finasteride—SRD5A1—Metabolism—GSTT1—kidney cancer	0.000117	0.00248	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ACHE—kidney cancer	0.000117	0.00248	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTT1—kidney cancer	0.000117	0.00248	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ACHE—kidney cancer	0.000117	0.00248	CbGpPWpGaD
Finasteride—Pruritus—Doxorubicin—kidney cancer	0.000117	0.000862	CcSEcCtD
Finasteride—AKR1D1—Metabolism—ITPR2—kidney cancer	0.000115	0.00243	CbGpPWpGaD
Finasteride—CYP3A4—renal system—kidney cancer	0.000111	0.032	CbGeAlD
Finasteride—SRD5A2—Metabolism—SCARB1—kidney cancer	0.000111	0.00235	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SCARB1—kidney cancer	0.000111	0.00235	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS1—kidney cancer	0.00011	0.00233	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS1—kidney cancer	0.00011	0.00233	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00011	0.00232	CbGpPWpGaD
Finasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000109	0.00232	CbGpPWpGaD
Finasteride—Dizziness—Doxorubicin—kidney cancer	0.000109	0.000805	CcSEcCtD
Finasteride—SRD5A1—Metabolism—PSMD7—kidney cancer	0.000108	0.00228	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PSMD7—kidney cancer	0.000108	0.00228	CbGpPWpGaD
Finasteride—CYP3A4—kidney—kidney cancer	0.000107	0.031	CbGeAlD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000106	0.00225	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000106	0.00224	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ACHE—kidney cancer	0.000104	0.00221	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTT1—kidney cancer	0.000104	0.00221	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000104	0.00221	CbGpPWpGaD
Finasteride—Rash—Doxorubicin—kidney cancer	0.000104	0.000768	CcSEcCtD
Finasteride—Dermatitis—Doxorubicin—kidney cancer	0.000104	0.000767	CcSEcCtD
Finasteride—Headache—Doxorubicin—kidney cancer	0.000103	0.000763	CcSEcCtD
Finasteride—SRD5A2—Metabolism—BCHE—kidney cancer	0.000102	0.00216	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—BCHE—kidney cancer	0.000102	0.00216	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC5A5—kidney cancer	0.000101	0.00214	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC5A5—kidney cancer	0.000101	0.00214	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SCARB1—kidney cancer	9.89e-05	0.00209	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS1—kidney cancer	9.79e-05	0.00207	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.77e-05	0.00207	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC2A1—kidney cancer	9.74e-05	0.00206	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC2A1—kidney cancer	9.74e-05	0.00206	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PSMD7—kidney cancer	9.6e-05	0.00203	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.45e-05	0.002	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.45e-05	0.002	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTT1—kidney cancer	9.34e-05	0.00198	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—BCHE—kidney cancer	9.1e-05	0.00193	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC5A5—kidney cancer	8.99e-05	0.0019	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTP1—kidney cancer	8.96e-05	0.0019	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTP1—kidney cancer	8.83e-05	0.00187	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—PTGS1—kidney cancer	8.75e-05	0.00185	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC2A1—kidney cancer	8.68e-05	0.00184	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.42e-05	0.00178	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.24e-05	0.00175	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.24e-05	0.00175	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTM1—kidney cancer	8.23e-05	0.00174	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTP1—kidney cancer	8.12e-05	0.00172	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTP1—kidney cancer	8.12e-05	0.00172	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTM1—kidney cancer	8.12e-05	0.00172	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.92e-05	0.00168	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP1A1—kidney cancer	7.8e-05	0.00165	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP1A1—kidney cancer	7.7e-05	0.00163	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ABCB1—kidney cancer	7.69e-05	0.00163	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ABCB1—kidney cancer	7.69e-05	0.00163	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.66e-05	0.00162	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	7.53e-05	0.0016	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTM1—kidney cancer	7.46e-05	0.00158	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTM1—kidney cancer	7.46e-05	0.00158	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	7.39e-05	0.00157	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.35e-05	0.00156	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTP1—kidney cancer	7.24e-05	0.00153	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP1A1—kidney cancer	7.08e-05	0.0015	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP1A1—kidney cancer	7.08e-05	0.0015	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACY1—kidney cancer	6.86e-05	0.00145	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ABCB1—kidney cancer	6.85e-05	0.00145	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTM1—kidney cancer	6.65e-05	0.00141	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTP1—kidney cancer	6.48e-05	0.00137	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	6.39e-05	0.00135	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP1A1—kidney cancer	6.31e-05	0.00134	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.09e-05	0.00129	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.01e-05	0.00127	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTM1—kidney cancer	5.95e-05	0.00126	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	5.87e-05	0.00124	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PDHB—kidney cancer	5.84e-05	0.00124	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—POMC—kidney cancer	5.82e-05	0.00123	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.81e-05	0.00123	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.81e-05	0.00123	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	5.64e-05	0.00119	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	5.56e-05	0.00118	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CCBL1—kidney cancer	5.49e-05	0.00116	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—POMC—kidney cancer	5.28e-05	0.00112	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—POMC—kidney cancer	5.28e-05	0.00112	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.18e-05	0.0011	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACY1—kidney cancer	4.96e-05	0.00105	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.94e-05	0.00105	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPAT—kidney cancer	4.76e-05	0.00101	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GLIPR1—kidney cancer	4.76e-05	0.00101	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—POMC—kidney cancer	4.7e-05	0.000996	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.54e-05	0.000962	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APRT—kidney cancer	4.42e-05	0.000937	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FH—kidney cancer	4.42e-05	0.000937	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.34e-05	0.00092	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PDHB—kidney cancer	4.22e-05	0.000894	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS2—kidney cancer	4.21e-05	0.000891	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS2—kidney cancer	4.21e-05	0.000891	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—POMC—kidney cancer	4.21e-05	0.000891	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPC3—kidney cancer	4.16e-05	0.000881	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.07e-05	0.000862	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA2—kidney cancer	4.05e-05	0.000857	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CCBL1—kidney cancer	3.97e-05	0.00084	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALAD—kidney cancer	3.94e-05	0.000835	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ST3GAL2—kidney cancer	3.85e-05	0.000815	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALDH1A1—kidney cancer	3.76e-05	0.000797	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS2—kidney cancer	3.75e-05	0.000795	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.68e-05	0.00078	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTEN—kidney cancer	3.67e-05	0.000777	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTEN—kidney cancer	3.67e-05	0.000777	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC5A3—kidney cancer	3.61e-05	0.000764	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PGK1—kidney cancer	3.61e-05	0.000764	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LDHB—kidney cancer	3.54e-05	0.000749	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPAT—kidney cancer	3.44e-05	0.000729	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GLIPR1—kidney cancer	3.44e-05	0.000729	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTEN—kidney cancer	3.27e-05	0.000693	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APRT—kidney cancer	3.2e-05	0.000677	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FH—kidney cancer	3.2e-05	0.000677	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA9—kidney cancer	3.07e-05	0.000649	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.01e-05	0.000638	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPC3—kidney cancer	3.01e-05	0.000637	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.97e-05	0.000629	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA2—kidney cancer	2.92e-05	0.000619	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALAD—kidney cancer	2.85e-05	0.000604	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.78e-05	0.000589	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.77e-05	0.000586	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.73e-05	0.000578	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.72e-05	0.000576	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.62e-05	0.000556	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CRABP1—kidney cancer	2.61e-05	0.000552	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PGK1—kidney cancer	2.61e-05	0.000552	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A3—kidney cancer	2.61e-05	0.000552	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CA—kidney cancer	2.59e-05	0.000548	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CA—kidney cancer	2.59e-05	0.000548	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.59e-05	0.000548	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LDHB—kidney cancer	2.56e-05	0.000541	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ITPR2—kidney cancer	2.42e-05	0.000513	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CA—kidney cancer	2.31e-05	0.000489	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACY1—kidney cancer	2.31e-05	0.000489	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA9—kidney cancer	2.22e-05	0.000469	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACHE—kidney cancer	2.21e-05	0.000468	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTT1—kidney cancer	2.21e-05	0.000468	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SCARB1—kidney cancer	2.09e-05	0.000443	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS1—kidney cancer	2.07e-05	0.000439	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PSMD7—kidney cancer	2.03e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PDHB—kidney cancer	1.96e-05	0.000416	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—POMC—kidney cancer	1.96e-05	0.000414	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—BCHE—kidney cancer	1.93e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.9e-05	0.000403	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CRABP1—kidney cancer	1.88e-05	0.000399	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CCBL1—kidney cancer	1.84e-05	0.000391	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.84e-05	0.000389	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ITPR2—kidney cancer	1.75e-05	0.000371	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.6e-05	0.000339	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPAT—kidney cancer	1.6e-05	0.000339	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTT1—kidney cancer	1.6e-05	0.000338	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACHE—kidney cancer	1.6e-05	0.000338	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTP1—kidney cancer	1.53e-05	0.000325	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SCARB1—kidney cancer	1.51e-05	0.00032	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS1—kidney cancer	1.5e-05	0.000317	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APRT—kidney cancer	1.49e-05	0.000315	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FH—kidney cancer	1.49e-05	0.000315	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PSMD7—kidney cancer	1.47e-05	0.000311	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCB1—kidney cancer	1.45e-05	0.000307	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTM1—kidney cancer	1.41e-05	0.000298	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPC3—kidney cancer	1.4e-05	0.000296	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—BCHE—kidney cancer	1.39e-05	0.000295	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.37e-05	0.000291	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA2—kidney cancer	1.36e-05	0.000288	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.33e-05	0.000283	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.33e-05	0.000281	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALAD—kidney cancer	1.32e-05	0.000281	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.29e-05	0.000274	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.26e-05	0.000268	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PGK1—kidney cancer	1.21e-05	0.000257	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.21e-05	0.000257	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LDHB—kidney cancer	1.19e-05	0.000252	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTP1—kidney cancer	1.11e-05	0.000235	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCB1—kidney cancer	1.05e-05	0.000222	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA9—kidney cancer	1.03e-05	0.000218	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTM1—kidney cancer	1.02e-05	0.000216	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—POMC—kidney cancer	9.95e-06	0.000211	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1A1—kidney cancer	9.65e-06	0.000204	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CRABP1—kidney cancer	8.76e-06	0.000186	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ITPR2—kidney cancer	8.14e-06	0.000173	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS2—kidney cancer	7.94e-06	0.000168	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTT1—kidney cancer	7.43e-06	0.000157	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACHE—kidney cancer	7.43e-06	0.000157	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—POMC—kidney cancer	7.19e-06	0.000152	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SCARB1—kidney cancer	7.03e-06	0.000149	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS1—kidney cancer	6.96e-06	0.000147	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTEN—kidney cancer	6.92e-06	0.000147	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PSMD7—kidney cancer	6.83e-06	0.000145	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—BCHE—kidney cancer	6.47e-06	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.39e-06	0.000135	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.17e-06	0.000131	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS2—kidney cancer	5.74e-06	0.000122	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTP1—kidney cancer	5.15e-06	0.000109	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTEN—kidney cancer	5e-06	0.000106	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CA—kidney cancer	4.88e-06	0.000103	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCB1—kidney cancer	4.87e-06	0.000103	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTM1—kidney cancer	4.73e-06	0.0001	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.48e-06	9.5e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.53e-06	7.48e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—POMC—kidney cancer	3.34e-06	7.08e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS2—kidney cancer	2.67e-06	5.65e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTEN—kidney cancer	2.33e-06	4.93e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.64e-06	3.48e-05	CbGpPWpGaD
